Clinical Trial Update: An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

An early-phase (Phase 1) dose-escalation study evaluating AbGn-7 alone and in combination with FOLFOX7 in patients with advanced solid tumors, including gastric…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• AbGn-7 (AbGn-7)
• FOLFOX7 (FOLFOX7)

Snippet

Sponsor: AbGenomics B.V Taiwan Branch | Conditions: Solid Tumor of Epithelial Origin, Gastric Cancer | Phase 1 | Status: COMPLETED